John H Sampson

7PUBLICATIONS
29CO-AUTHORS
Tumour immunologyBiomaterialsMolecular targetsInnate immunityGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 03, 2023
CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D-NKG2DL axis.

Emily C Lerner, Karolina I Woroniecka, Vincent M D'Anniballe

|Oct 30, 2022
Neuronal CaMKK2 promotes immunosuppression and checkpoint blockade resistance in glioblastoma.

William H Tomaszewski, Jessica Waibl-Polania, Molly Chakraborty

|Jan 14, 2021
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy.

Matthias Gromeier, Michael C Brown, Gao Zhang

|Aug 20, 2020
Temozolomide treatment outcomes and immunotherapy efficacy in brain tumor.

Kelly M Hotchkiss, John H Sampson

Pageof 2